Navigation Links
GW Pharmaceuticals Announces Results of MS Spasticity Study Confirming Sativex Has No Long-Term Negative Effect on Cognition
Date:8/4/2013

LONDON, Aug. 5, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (NASDAQ: GWPH, AIM: GWP, "GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces top-line results from a 12 month placebo-controlled study of Sativex in patients with spasticity due to Multiple Sclerosis (MS). The study results confirm the reassuring safety profile of Sativex and provide further evidence of long-term efficacy.

The study was a 12 month multicentre, double-blind, randomised parallel group, placebo-controlled study in 121 patients with MS spasticity. The study was required as a post-approval commitment by the UK regulatory authority, the Medicines and Healthcare products Regulatory agency (MHRA), with the primary objective of evaluating whether Sativex may have long term adverse effects on cognitive function or mood. The primary endpoint was the change in cognitive function as assessed by the total Paced Auditory Serial Addition Test (PASAT) score from baseline to end of treatment.  Mood was assessed by the Beck Depression Inventory-II.

There was a slight improvement in the PASAT score from the beginning to the end of the study in both the Sativex and placebo groups, thus confirming that there is no evidence of long-term cognitive impairment in patients taking Sativex compared with those taking placebo.  Similarly, the change in mood over the 12 month period was more or less identical in the Sativex and the placebo group, confirming no untoward effect on mood.

The key efficacy secondary endpoints were the global impression of change scores as assessed by the patient, physician and carer. Each of these endpoints was highly significantly in favour of Sativex (p<0.0001, p=0.001 and p=0.004 respectively).

Detailed data from this study is due to be presented at the 29th Congress
'/>"/>

SOURCE GW Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GW Pharmaceuticals plc Reports 2013 Third Quarter Financial Results
2. AcelRx Pharmaceuticals to Hold Second Quarter 2013 Financial Results Conference Call and Webcast on August 12, 2013
3. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
4. OPTIMER PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Optimer Pharmaceuticals, Inc. in Connection with Sale of Company to Cubist Pharmaceuticals, Inc.
5. Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
6. Auxilium Pharmaceuticals, Inc, Announces Second Quarter 2013 Financial Results
7. Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
8. Arisaph Pharmaceuticals Awarded Phase I STTR Grant To Develop Small Molecule Immune Modulators
9. Avion Pharmaceuticals, LLC, receives top accolades for trade and marketing achievements at the 11th Annual American Business Awards (The "Stevie Awards")
10. Amerigen Pharmaceuticals Limited today announced it had entered into a collaboration agreement with Forest Laboratories Inc. regarding the development of a number of specialty generic products.
11. Vanda Pharmaceuticals Reports Second Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... /CNW/ - Canadians face wait times of over 460 days in order ... plans, according to a new IMS Brogan report commissioned ... 16 out of 18 similar OECD countries. "It,s unimaginable ... new medicines were included in public plans, ranking Canada ... Brett Skinner , Rx&D Executive Director, Health and Economic Policy. ...
(Date:5/21/2015)... BERKELEY, Kalifornien, und KOPENHAGEN, Dänemark, 21. Mai ... , ein Weltmarktführer bei der klinischen und ... bekannt, man werde im Rahmen der weltweiten ... ca. 14.000 Liter Produktionskapazität erweitern. ... Kunden erhalten durch das innovative Einweg Bioreactor ...
(Date:5/21/2015)... -- Townsend Design announced the North America ... shell single-upright osteoarthritis (OA) knee brace. This off-the-shelf or ... reducing load on the side of the knee that ... product in other countries will begin in July. ... rigid frame and quick release buckles which make application ...
Breaking Medicine Technology:Canadians lagging well behind similar countries on access to new medicines: report 2Canadians lagging well behind similar countries on access to new medicines: report 3CMC Biologics erweitert GMP-Produktionskapazität in Europa 2CMC Biologics erweitert GMP-Produktionskapazität in Europa 3Townsend Announces Launch Of New Osteoarthritis Knee Brace 2
... -- A Pebble Beach golf tournament pays off big ... researchers took home the top prize: a $150,000 contribution from ... MS (BAMS) organization. The money will fund important studies on ... Texas Health Science Center at Houston . , , ...
... , BRIDGEWATER, N.J., July 6 ... today that the results of the long-term, 5-year study of ... of retinopathy in patients with type 2 diabetes, published on-line ... showed similar effects on retinopathy and overall safety in the ...
Cached Medicine Technology:Clay Walker's Band Against MS Foundation Donates $150,000 To Support Multiple Sclerosis Research 25-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH 25-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH 35-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH 45-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH 5
(Date:5/22/2015)... India Network Foundation sponsors various community events ... India. India Network Visitor Health insurance is one ... help hundreds and thousands of families every year. ... by famous playback singer from Mumbai, Smt. Anuradha Paudwal ... Central Florida activities. , Anuradha Paudwal is ...
(Date:5/21/2015)... 2015 The Johns Hopkins Alliance for ... Baltimore Commercial Advisory Board has selected a research project ... as one of two $50,000 Abell Foundation Award for ... known as Anklebot. Developed by the VA Maryland ... the University of Maryland School of Medicine and Massachusetts ...
(Date:5/21/2015)... May 21, 2015 Jhon Tamayo, ... and Sequence, is excited to announce the launch ... was previously available for use exclusively in Tamayo's NY ... is that it's mathematically designed with symmetrical lines ... and muscle strains, commonly experienced by both beginner ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Shimadzu ... AOC-6000 robotic autosampler, which features new time-saving tools ... standard injection techniques: liquid, headspace, and solid-phase microextraction ... This new tool allows users to seamlessly change ... the GC/MS. , The new autosampler allows for ...
(Date:5/21/2015)... 2015 Drews Dental Services is proud to ... Mary’s d’Youville Pavilion to provide dental support services and education ... can be challenging for the individual as well as the ... address include:, , Dry mouth, which can ... can contribute to increased cavities. , The care ...
Breaking Medicine News(10 mins):Health News:India Network Visitor Health Insurance Announces Corporate Sponsorship of Anuradha Paudwal Musical in Orlando to Help Fundraise for Hindu Society of Central Florida. 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 3Health News:NY's Atmananda Yoga Studio Launches Its Patented "Alignment" Yoga Mat for Public Sale 2Health News:Shimadzu’s New AOC-6000 Autosampler Makes Automated Sample Introduction Simple and Efficient 2Health News:Peter J. Drews, DDS Provides Dental Support Services in Partnership with St. Mary’s d’Youville Pavilion 2
... RES-Q,s ... Product Evaluations and In-depth, Confidential Interviews Conducted by KLAS with Hospital Executives and Managers ... Chicago and ... Healthcare Systems announced that its RES-Q® Labor Resource Management system was ranked #1 among ...
... , , , ... forces with (RED) to empower parents across the globe to participate in ... encouraging parents to GO ... go outside, go discover, go experience. Through ... opportunity for our customers to not only improve their own lives, but ...
... Leg Cramps Can be Red Flag for Heart Disease ... many as 4.5 million American women have a common and dangerous vascular ... September is Peripheral Arterial Disease (P.A.D.) Awareness Month , and the ... have launched a national effort to inform Americans about the impact of ...
... ... packaging and Sun Chemical to provide comprehensive security solution which includes PHARMORX,s new ... solutions which help prevent counterfeiting and diversion of products, within the pharmaceutical, food ... ...
... , , SAN DIEGO, ... office has issued patent US 7,572,452 B2, titled "Method for Stimulating ... patent, and Professor Sunghoon Kim, a scientific co-founder of aTyr Pharma, ... property portfolio and the fifteenth filed patent related to aTyr Pharma,s ...
... , BOSTON, Sept. 9 ... care organization that represents the interests of physicians, raises new ... to access, quality, and cost of medical care in the ... noted physicians and economists headed by Richard "Buz" Cooper, MD, ...
Cached Medicine News:Health News:RES-Q Labor Resource Management Ranked as the Top Staff Scheduling System Solution in KLAS 2009 Special Report 2Health News:'Go and Good Things Happen' with (BUGABOO)(RED) 2Health News:'Go and Good Things Happen' with (BUGABOO)(RED) 3Health News:'Go and Good Things Happen' with (BUGABOO)(RED) 4Health News:WomenHeart and P.A.D. Coalition Join Forces to Educate Women about Peripheral Arterial Disease 2Health News:WomenHeart and P.A.D. Coalition Join Forces to Educate Women about Peripheral Arterial Disease 3Health News:Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution 2Health News:Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution 3Health News:Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution 4Health News:Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution 5Health News:Fifteenth US Patent Issued for aTyr Pharma Novel Biotherapeutic 2Health News:New Report to President and Congress Addresses 'Serious Oversights' in National Health Care Debate 2
... Reagents provide molecular labs a more advanced ... using our MGB technology, combined with post-PCR ... able to provide molecular labs more powerful ... specific organisms or genetic mutations associated with ...
... Reagents provide molecular labs a more advanced ... using our MGB technology, combined with post-PCR ... able to provide molecular labs more powerful ... specific organisms or genetic mutations associated with ...
... molecular labs a more advanced alternative for ... MGB technology, combined with post-PCR dissociation melt ... provide molecular labs more powerful tools for ... or genetic mutations associated with disease, as ...
... is the latest and most advanced fecal ... product line. An immunochemical FOBT (iFOBT) with ... clinically proven to detect bleeding associated with ... FOBTs. Because of its superior specificity for ...
Medicine Products: